BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barbara G, De Giorgio R, Stanghellini V, Cremon C, Salvioli B, Corinaldesi R. New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther. 2004;20 Suppl 2:1-9. [PMID: 15335408 DOI: 10.1111/j.1365-2036.2004.02036.x] [Cited by in Crossref: 121] [Cited by in F6Publishing: 130] [Article Influence: 7.1] [Reference Citation Analysis]
Number Citing Articles
1 Cremon C, Pallotti F, Bacchilega M, Stanghellini V, Corinaldesi R, Barbara G. Antiflagellin antibodies suggest infective participation in irritable bowel syndrome pathogenesis. Expert Rev Gastroenterol Hepatol. 2008;2:735-740. [PMID: 19090734 DOI: 10.1586/17474124.2.6.735] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
2 Lee JY, Kim N, Kim YS, Nam RH, Ham MH, Lee HS, Jo W, Shim Y, Choi YJ, Yoon H, Shin CM, Lee DH. Repeated Water Avoidance Stress Alters Mucosal Mast Cell Counts, Interleukin-1β Levels with Sex Differences in the Distal Colon of Wistar Rats. J Neurogastroenterol Motil 2016;22:694-704. [PMID: 27466288 DOI: 10.5056/jnm16007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kokkotou E, Conboy LA, Ziogas DC, Quilty MT, Kelley JM, Davis RB, Lembo AJ, Kaptchuk TJ. Serum correlates of the placebo effect in irritable bowel syndrome. Neurogastroenterol Motil 2010;22:285-e81. [PMID: 20028464 DOI: 10.1111/j.1365-2982.2009.01440.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
4 Barbara G, Cremon C, De Giorgio R, Dothel G, Zecchi L, Bellacosa L, Carini G, Stanghellini V, Corinaldesi R. Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome. Curr Gastroenterol Rep. 2011;13:308-315. [PMID: 21537962 DOI: 10.1007/s11894-011-0195-7] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 6.9] [Reference Citation Analysis]
5 Akiho H, Ihara E, Nakamura K. Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome. World J Gastrointest Pathophysiol 2010; 1(3): 97-105 [PMID: 21607147 DOI: 10.4291/wjgp.v1.i3.97] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 60] [Article Influence: 5.1] [Reference Citation Analysis]
6 Chang JY, Talley NJ. Current and emerging therapies in irritable bowel syndrome: from pathophysiology to treatment. Trends Pharmacol Sci. 2010;31:326-334. [PMID: 20554042 DOI: 10.1016/j.tips.2010.04.008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
7 Mikocka-Walus AA, Turnbull DA, Andrews JM, Moulding NT, Wilson IG, Harley HNJ.  Psychological problems in gastroenterology outpatients: a South Australian experience. Psychological co-morbidity in IBD, IBS and hepatitis C. : Clinical Practice and Epidemiology in Mental Health 2008; . [PMID: 18500977 DOI: 10.1186/1745-0179-4-15] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
8 Watanabe K, Kato J, Zhu J, Oda H, Ishiwata-Endo H, Moss J. Enhanced sensitivity to cholera toxin in female ADP-ribosylarginine hydrolase (ARH1)-deficient mice. PLoS One 2018;13:e0207693. [PMID: 30500844 DOI: 10.1371/journal.pone.0207693] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
9 Hauser G, Pletikosic S, Tkalcic M. Cognitive behavioral approach to understanding irritable bowel syndrome. World J Gastroenterol 2014; 20(22): 6744-6758 [PMID: 24944466 DOI: 10.3748/wjg.v20.i22.6744] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
10 Park MI, Camilleri M. Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review. Neurogastroenterol Motil. 2006;18:595-607. [PMID: 16918724 DOI: 10.1111/j.1365-2982.2005.00745.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 70] [Article Influence: 6.2] [Reference Citation Analysis]
11 Barbara G, Cremon C, Pallotti F, De Giorgio R, Stanghellini V, Corinaldesi R. Postinfectious irritable bowel syndrome. J Pediatr Gastroenterol Nutr. 2009;48:S95-S97. [PMID: 19300138 DOI: 10.1097/mpg.0b013e3181a15e2e] [Cited by in Crossref: 46] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
12 Bafutto M, Almeida JR, Leite NV, Costa MB, Oliveira EC, Resende-Filho J. Treatment of diarrhea-predominant irritable bowel syndrome with mesalazine and/or Saccharomyces boulardii. Arq Gastroenterol. 2013;50:304-309. [PMID: 24474234 DOI: 10.1590/s0004-28032013000400012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
13 Soyturk M, Akpinar H, Gurler O, Pozio E, Sari I, Akar S, Akarsu M, Birlik M, Onen F, Akkoc N. Irritable bowel syndrome in persons who acquired trichinellosis. Am J Gastroenterol. 2007;102:1064-1069. [PMID: 17313500 DOI: 10.1111/j.1572-0241.2007.01084.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
14 Soares RL, Moreira-Filho PF, Maneschy CP, Breijão JF, Schmidte NM. The prevalence and clinical characteristics of primary headache in irritable bowel syndrome: a subgroup of the functional somatic syndromes. Arq Gastroenterol 2013;50:281-4. [PMID: 24474230 DOI: 10.1590/S0004-28032013000400008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
15 Bellini M, Gambaccini D, Stasi C, Urbano MT, Marchi S, Usai-Satta P. Irritable bowel syndrome: A disease still searching for pathogenesis, diagnosis and therapy. World J Gastroenterol 2014; 20(27): 8807-8820 [PMID: 25083055 DOI: 10.3748/wjg.v20.i27.8807] [Cited by in F6Publishing: 32] [Reference Citation Analysis]
16 Morken MH, Lind RA, Valeur J, Wilhelmsen I, Berstad A. Subjective health complaints and quality of life in patients with irritable bowel syndrome following Giardia lamblia infection: a case control study. Scand J Gastroenterol. 2009;44:308-313. [PMID: 19031266 DOI: 10.1080/00365520802588091] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
17 Kalliomäki MA. Food allergy and irritable bowel syndrome. Curr Opin Gastroenterol 2005;21:708-11. [PMID: 16220050 DOI: 10.1097/01.mog.0000181712.81657.0a] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
18 Miwa H. Why dyspepsia can occur without organic disease: pathogenesis and management of functional dyspepsia. J Gastroenterol 2012;47:862-71. [DOI: 10.1007/s00535-012-0625-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
19 Barbara G, Zecchi L, Barbaro R, Cremon C, Bellacosa L, Marcellini M, De Giorgio R, Corinaldesi R, Stanghellini V. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. J Clin Gastroenterol. 2012;46 Suppl:S52-S55. [PMID: 22955358 DOI: 10.1097/mcg.0b013e318264e918] [Cited by in Crossref: 53] [Cited by in F6Publishing: 28] [Article Influence: 6.6] [Reference Citation Analysis]
20 Carroccio A, Iacono G. Review article: chronic constipation and food hypersensitivity ? an intriguing relationship. Aliment Pharmacol Ther 2006;24:1295-304. [DOI: 10.1111/j.1365-2036.2006.03125.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
21 García Carrasco M, Mendoza Pinto C, López Colombo A, Méndez Martínez S, Andari Sawaya R, Muñoz Guarneros M, Vázquez De Lara L, Lescas Hernández M, Montiel Jarquín A, Ramos Álvarez G, Schmulson M. Irritable bowel syndrome-type symptoms in female patients with mild systemic lupus erythematosus: frequency, related factors and quality of life. Neurogastroenterol Motil 2013;25:958-66. [DOI: 10.1111/nmo.12230] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
22 Zhao Y, Zou D, Wang R, Ma X, Yan X, Man X, Gao L, Fang J, Yan H, Kang X. Dyspepsia and irritable bowel syndrome in China: a population-based endoscopy study of prevalence and impact. Aliment Pharmacol Ther. 2010;32:562-572. [PMID: 20497141 DOI: 10.1111/j.1365-2036.2010.04376.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 4.9] [Reference Citation Analysis]
23 Chung CS, Chang PF, Liao CH, Lee TH, Chen Y, Lee YC, Wu MS, Wang HP, Ni YH. Differences of microbiota in small bowel and faeces between irritable bowel syndrome patients and healthy subjects. Scand J Gastroenterol. 2016;51:410-419. [PMID: 26595305 DOI: 10.3109/00365521.2015.1116107] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 6.7] [Reference Citation Analysis]
24 Chun E, Yoon S, Parveen A, Jin M. Alleviation of Irritable Bowel Syndrome-Like Symptoms and Control of Gut and Brain Responses with Oral Administration of Dolichos lablab L. in a Mouse Model. Nutrients 2018;10:E1475. [PMID: 30309025 DOI: 10.3390/nu10101475] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
25 Min YW, Park SU, Jang YS, Kim YH, Rhee PL, Ko SH, Joo N, Kim SI, Kim CH, Chang DK. Effect of composite yogurt enriched with acacia fiber and Bifidobacterium lactisWorld J Gastroenterol 2012; 18(33): 4563-4569 [PMID: 22969230 DOI: 10.3748/wjg.v18.i33.4563] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
26 Turco R, Boccia G, Miele E, Giannetti E, Buonavolontà R, Quitadamo P, Auricchio R, Staiano A. The association of coeliac disease in childhood with functional gastrointestinal disorders: a prospective study in patients fulfilling Rome III criteria. Aliment Pharmacol Ther 2011;34:783-9. [PMID: 21790684 DOI: 10.1111/j.1365-2036.2011.04787.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
27 Hilmi I, Hartono JL, Pailoor J, Mahadeva S, Goh KL. Low prevalence of 'classical' microscopic colitis but evidence of microscopic inflammation in Asian irritable bowel syndrome patients with diarrhoea. BMC Gastroenterol 2013;13:80. [PMID: 23651739 DOI: 10.1186/1471-230X-13-80] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
28 徐俊荣, 罗金燕, 尚磊, 孔武明. 从肠肌间神经丛抑制性神经递质的改变探讨IBS不同亚型的发病机制. 世界华人消化杂志 2005; 13(19): 2332-2338 [DOI: 10.11569/wcjd.v13.i19.2332] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
29 Bergonzelli GE, Blum S, Brussow H, Corthésy-Theulaz I. Probiotics as a treatment strategy for gastrointestinal diseases? Digestion. 2005;72:57-68. [PMID: 16113543 DOI: 10.1159/000087638] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 3.4] [Reference Citation Analysis]
30 Li J, Zhu W, Liu W, Wu Y, Wu B. Rifaximin for Irritable Bowel Syndrome: A Meta-Analysis of Randomized Placebo-Controlled Trials. Medicine (Baltimore) 2016;95:e2534. [PMID: 26825893 DOI: 10.1097/MD.0000000000002534] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 3.2] [Reference Citation Analysis]
31 Lee YJ, Park KS. Irritable bowel syndrome: Emerging paradigm in pathophysiology. World J Gastroenterol 2014; 20(10): 2456-2469 [PMID: 24627583 DOI: 10.3748/wjg.v20.i10.2456] [Cited by in CrossRef: 79] [Cited by in F6Publishing: 64] [Article Influence: 11.3] [Reference Citation Analysis]
32 Fernández-Blanco JA, Estévez J, Shea-Donohue T, Martínez V, Vergara P. Changes in Epithelial Barrier Function in Response to Parasitic Infection: Implications for IBD Pathogenesis. J Crohns Colitis 2015;9:463-76. [PMID: 25820018 DOI: 10.1093/ecco-jcc/jjv056] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
33 Ferreira AI, Garrido M, Castro-Poças F. Irritable Bowel Syndrome: News from an Old Disorder. GE Port J Gastroenterol 2020;27:255-68. [PMID: 32775547 DOI: 10.1159/000503757] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
34 Darkoh C, Comer L, Zewdie G, Harold S, Snyder N, Dupont HL. Chemotactic chemokines are important in the pathogenesis of irritable bowel syndrome. PLoS One. 2014;9:e93144. [PMID: 24667736 DOI: 10.1371/journal.pone.0093144] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
35 Ghadir MR, Poradineh M, Sotodeh M, Ansari R, Kolahdoozan S, Hormati A, Yousefi MH, Mirzaei S, Vahedi H. Mesalazine Has No Effect on Mucosal Immune Biomarkers in Patients with Diarrhea-Dominant Irritable Bowel Syndrome Referred to Shariati Hospital: A Randomized Double-Blind, Placebo-Controlled Trial. Middle East J Dig Dis 2017;9:20-5. [PMID: 28316762 DOI: 10.15171/mejdd.2016.47] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Saad AG. Normal Quantity and Distribution of Mast Cells and Eosinophils in the Pediatric Colon. Pediatr Dev Pathol 2011;14:294-300. [DOI: 10.2350/10-07-0878-oa.1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
37 von Mentzer B, Murata Y, Ahlstedt I, Lindström E, Martínez V. Functional CRF receptors in BON cells stimulate serotonin release. Biochem Pharmacol. 2007;73:805-813. [PMID: 17184738 DOI: 10.1016/j.bcp.2006.11.019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
38 Miwa H, Watari J, Fukui H, Oshima T, Tomita T, Sakurai J, Kondo T, Matsumoto T. Current understanding of pathogenesis of functional dyspepsia. J Gastroenterol Hepatol. 2011;26 Suppl 3:53-60. [PMID: 21443711 DOI: 10.1111/j.1440-1746.2011.06633.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
39 Cremon C, Carini G, De Giorgio R, Stanghellini V, Corinaldesi R, Barbara G. Intestinal dysbiosis in irritable bowel syndrome: etiological factor or epiphenomenon? Expert Review of Molecular Diagnostics 2014;10:389-93. [DOI: 10.1586/erm.10.33] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
40 Şahin-Eryılmaz G, Başak K, Çakır-Madenci Ö, Koç H, Tüzün S, Dolapçıoğlu C, Ahıshalı E, Dabak MR. Relationship between irritable bowel syndrome and plasma and tissue ghrelin levels. Turk J Gastroenterol 2018;29:631-5. [PMID: 30289393 DOI: 10.5152/tjg.2018.17593] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Rusu F, Mocanu L, Dumitraşcu DL. Phenotypic features of patients with post-infectious irritable bowel syndrome. Med Pharm Rep 2019;92:239-45. [PMID: 31460504 DOI: 10.15386/mpr-1317] [Reference Citation Analysis]
42 Rinttilä T, Lyra A, Krogius-Kurikka L, Palva A. Real-time PCR analysis of enteric pathogens from fecal samples of irritable bowel syndrome subjects. Gut Pathog. 2011;3:6. [PMID: 21518462 DOI: 10.1186/1757-4749-3-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
43 Thompson A, Meah D, Ahmed N, Conniff-Jenkins R, Chileshe E, Phillips CO, Claypole TC, Forman DW, Row PE. Comparison of the antibacterial activity of essential oils and extracts of medicinal and culinary herbs to investigate potential new treatments for irritable bowel syndrome. BMC Complement Altern Med 2013;13:338. [PMID: 24283351 DOI: 10.1186/1472-6882-13-338] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
44 刘玮, 王承党. 结肠黏膜低度炎症对小鼠结肠PAR-2活化和内脏感觉过敏的诱发作用. 世界华人消化杂志 2010; 18(32): 3413-3419 [DOI: 10.11569/wcjd.v18.i32.3413] [Reference Citation Analysis]
45 Shin SP, Choi YM, Kim WH, Hong SP, Park JM, Kim J, Kwon O, Lee EH, Hahm KB. A double blind, placebo-controlled, randomized clinical trial that breast milk derived-Lactobacillus gasseri BNR17 mitigated diarrhea-dominant irritable bowel syndrome. J Clin Biochem Nutr 2018;62:179-86. [PMID: 29610559 DOI: 10.3164/jcbn.17-73] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
46 Guarino MP, Altomare A, Stasi E, Marignani M, Severi C, Alloni R, Dicuonzo G, Morelli L, Coppola R, Cicala M. Effect of acute mucosal exposure to Lactobacillus rhamnosus GG on human colonic smooth muscle cells. J Clin Gastroenterol. 2008;42 Suppl 3 Pt 2:S185-S190. [PMID: 18685510 DOI: 10.1097/mcg.0b013e31817e1cac] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
47 Pimentel M. Review of rifaximin as treatment for SIBO and IBS. Expert Opin Investig Drugs. 2009;18:349-358. [PMID: 19243285 DOI: 10.1517/13543780902780175] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 5.1] [Reference Citation Analysis]
48 Chang FY, Lu CL. Irritable bowel syndrome in the 21st century: perspectives from Asia or South-east Asia. J Gastroenterol Hepatol. 2007;22:4-12. [PMID: 17201873 DOI: 10.1111/j.1440-1746.2006.04672.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
49 Tort S, Balboa A, Marzo M, Carrillo R, Mínguez M, Valdepérez J, Alonso-Coello P, Mascort JJ, Ferrándiz J, Bonfill X, Piqué JM, Mearin F; Centro Cochrame Iberoamericano., Asociación Española de Gastroentología., Sociedad Española de Medicina de Familia y Comunitaria (SEMFYC). [Clinical practice guideline for irritable bowel syndrome]. Gastroenterol Hepatol 2006;29:467-521. [PMID: 17020681 DOI: 10.1157/13092567] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
50 Boyer J, Saint-paul M, Dadone B, Patouraux S, Vivinus M, Ouvrier D, Michiels J, Piche T, Tulic MK. Inflammatory cell distribution in colon mucosa as a new tool for diagnosis of irritable bowel syndrome: A promising pilot study. Neurogastroenterol Motil 2018;30:e13223. [DOI: 10.1111/nmo.13223] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
51 Ding Y, Lu B, Chen D, Meng L, Shen Y, Chen S. Proteomic analysis of colonic mucosa in a rat model of irritable bowel syndrome. Proteomics 2010;10:2620-30. [PMID: 20461717 DOI: 10.1002/pmic.200900572] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
52 Kushnir-Sukhov NM, Brittain E, Scott L, Metcalfe DD. Clinical correlates of blood serotonin levels in patients with mastocytosis. Eur J Clin Invest 2008;38:953-8. [PMID: 19021721 DOI: 10.1111/j.1365-2362.2008.02047.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
53 Furnari M, de Bortoli N, Martinucci I, Bodini G, Revelli M, Marabotto E, Moscatelli A, Del Nero L, Savarino E, Giannini EG, Savarino V. Optimal management of constipation associated with irritable bowel syndrome. Ther Clin Risk Manag 2015;11:691-703. [PMID: 26028974 DOI: 10.2147/TCRM.S54298] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
54 DuPont AW, DuPont HL. The intestinal microbiota and chronic disorders of the gut. Nat Rev Gastroenterol Hepatol. 2011;8:523-531. [PMID: 21844910 DOI: 10.1038/nrgastro.2011.133] [Cited by in Crossref: 204] [Cited by in F6Publishing: 189] [Article Influence: 20.4] [Reference Citation Analysis]
55 Pasqualetti V, Altomare A, Guarino MP, Locato V, Cocca S, Cimini S, Palma R, Alloni R, De Gara L, Cicala M. Antioxidant activity of inulin and its role in the prevention of human colonic muscle cell impairment induced by lipopolysaccharide mucosal exposure. PLoS One 2014;9:e98031. [PMID: 24837182 DOI: 10.1371/journal.pone.0098031] [Cited by in Crossref: 42] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
56 Kim JH, Sung I. Current Issues on Irritable Bowel Syndrome: Diet and Irritable Bowel Syndrome. Korean J Gastroenterol 2014;64:142. [DOI: 10.4166/kjg.2014.64.3.142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
57 Larsson MH, Miketa A, Martinez V. Lack of interaction between psychological stress and DSS-induced colitis affecting colonic sensitivity during colorectal distension in mice. Stress. 2009;12:434-444. [PMID: 19929445 DOI: 10.1080/10253890802626603] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
58 Brierley SM, Page AJ, Hughes PA, Adam B, Liebregts T, Cooper NJ, Holtmann G, Liedtke W, Blackshaw LA. Selective role for TRPV4 ion channels in visceral sensory pathways. Gastroenterology 2008;134:2059-69. [PMID: 18343379 DOI: 10.1053/j.gastro.2008.01.074] [Cited by in Crossref: 180] [Cited by in F6Publishing: 166] [Article Influence: 13.8] [Reference Citation Analysis]
59 Mansueto P, D’Alcamo A, Seidita A, Carroccio A. Food allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivity. World J Gastroenterol 2015; 21(23): 7089-7109 [PMID: 26109796 DOI: 10.3748/wjg.v21.i23.7089] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
60 Sachdev AH, Pimentel M. Antibiotics for irritable bowel syndrome: rationale and current evidence. Curr Gastroenterol Rep. 2012;14:439-445. [PMID: 22945316 DOI: 10.1007/s11894-012-0284-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
61 Romero-valdovinos M, Gudiño-ramírez A, Reyes-gordillo J, Martínez-flores WA, Ramírez-miranda ME, Maravilla P, Olivo-díaz A. Interleukin-8 and -10 gene polymorphisms in irritable bowel syndrome. Mol Biol Rep 2012;39:8837-43. [DOI: 10.1007/s11033-012-1745-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
62 Hod K, Ringel-Kulka T, Martin CF, Maharshak N, Ringel Y. High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome. J Clin Gastroenterol. 2016;50:227-232. [PMID: 25930973 DOI: 10.1097/mcg.0000000000000327] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 4.4] [Reference Citation Analysis]
63 venkova K, greenwood-van meerveld B. Long-lasting changes in small intestinal transport following the recovery from Trichinella spiralis infection. Neurogastroenterol Motil 2006;18:234-42. [DOI: 10.1111/j.1365-2982.2005.00753.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
64 Barbara G, Stanghellini V, Cremon C, De Giorgio R, Gargano L, Cogliandro R, Pallotti F, Corinaldesi R. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use. J Clin Gastroenterol 2008;42 Suppl 3 Pt 2:S214-7. [PMID: 18685517 DOI: 10.1097/MCG.0b013e31817da129] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
65 Wood JD. Histamine, mast cells, and the enteric nervous system in the irritable bowel syndrome, enteritis, and food allergies. Gut. 2006;55:445-447. [PMID: 16531524 DOI: 10.1136/gut.2005.079046] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
66 Patcharatrakul T, Gonlachanvit S. Outcome of Biofeedback Therapy in Dyssynergic Defecation Patients With and Without Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 2011;45:593-8. [DOI: 10.1097/mcg.0b013e31820c6001] [Cited by in Crossref: 38] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
67 Ruigómez A, García Rodríguez LA, Panés J. Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: influence of comorbidities. Clin Gastroenterol Hepatol 2007;5:465-9. [PMID: 17445753 DOI: 10.1016/j.cgh.2007.02.008] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 4.0] [Reference Citation Analysis]
68 Areeshi MY, Haque S, Panda AK, Mandal RK. A serotonin transporter gene (SLC6A4) polymorphism is associated with reduced risk of irritable bowel syndrome in American and Asian population: a meta-analysis. PLoS One. 2013;8:e75567. [PMID: 24069428 DOI: 10.1371/journal.pone.0075567] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
69 Mikocka-Walus AA, Turnbull DA, Moulding NT, Wilson IG, Andrews JM, Holtmann GJ. "It doesn't do any harm, but patients feel better": a qualitative exploratory study on gastroenterologists' perspectives on the role of antidepressants in inflammatory bowel disease. BMC Gastroenterol 2007;7:38. [PMID: 17892587 DOI: 10.1186/1471-230X-7-38] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
70 Hod K, Sperber AD, Ron Y, Boaz M, Dickman R, Berliner S, Halpern Z, Maharshak N, Dekel R. A double-blind, placebo-controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea-predominant IBS. Neurogastroenterol Motil. 2017;29. [PMID: 28271623 DOI: 10.1111/nmo.13037] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
71 Barbara G. Proteases in Irritable Bowel Syndrome: A Lot More Than Just Digestive Enzymes. Clinical Gastroenterology and Hepatology 2007;5:548-9. [DOI: 10.1016/j.cgh.2007.03.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
72 Bafutto M, Almeida JR, Leite NV, Oliveira EC, Gabriel-Neto S, Rezende-Filho J. Treatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine. Arq Gastroenterol. 2011;48:36-40. [PMID: 21537540 DOI: 10.1590/s0004-28032011000100008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
73 Elsenbruch S, Lucas A, Holtmann G, Haag S, Gerken G, Riemenschneider N, Langhorst J, Kavelaars A, Heijnen CJ, Schedlowski M. Public speaking stress-induced neuroendocrine responses and circulating immune cell redistribution in irritable bowel syndrome. Am J Gastroenterol. 2006;101:2300-2307. [PMID: 16952284 DOI: 10.1111/j.1572-0241.2006.00837.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.3] [Reference Citation Analysis]
74 Róka R, Ait-Belgnaoui A, Salvador-Cartier C, Garcia-Villar R, Fioramonti J, Eutamène H, Bueno L. Dexamethasone prevents visceral hyperalgesia but not colonic permeability increase induced by luminal protease-activated receptor-2 agonist in rats. Gut. 2007;56:1072-1078. [PMID: 17309885 DOI: 10.1136/gut.2006.115352] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
75 Zhou XP, Sha J, Huang L, Li TN, Zhang RR, Tang MD, Lin L, Li XL. Nesfatin-1/NUCB2 in the amygdala influences visceral sensitivity via glucocorticoid and mineralocorticoid receptors in male maternal separation rats. Neurogastroenterol Motil. 2016;28:1545-1553. [PMID: 27380730 DOI: 10.1111/nmo.12853] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
76 罗和生, 赵运志, 张法灿, 张国. 肥大细胞在肠易激综合征发病机制中的研究进展. 世界华人消化杂志 2012; 20(19): 1747-1751 [DOI: 10.11569/wcjd.v20.i19.1747] [Reference Citation Analysis]
77 Ihara E, Akiho H, Nakamura K, Turner SR, MacDonald JA. MAPKs represent novel therapeutic targets for gastrointestinal motility disorders. World J Gastrointest Pathophysiol 2011; 2(2): 19-25 [PMID: 21607162 DOI: 10.4291/wjgp.v2.i2.19] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
78 Ozan ZT, Tanik N, Inan LE. Constipation is associated with tension type headache in women. Arq Neuro-Psiquiatr 2019;77:161-5. [DOI: 10.1590/0004-282x20190015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
79 López-Pérez AE, Nurgali K, Abalo R. Painful neurotrophins and their role in visceral pain. Behav Pharmacol 2018;29:120-39. [PMID: 29543647 DOI: 10.1097/FBP.0000000000000386] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
80 Niv E, Halak A, Tiommny E, Yanai H, Strul H, Naftali T, Vaisman N. Randomized clinical study: Partially hydrolyzed guar gum (PHGG) versus placebo in the treatment of patients with irritable bowel syndrome. Nutr Metab (Lond) 2016;13:10. [PMID: 26855665 DOI: 10.1186/s12986-016-0070-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
81 Zhang FM, Li S, Ding L, Xiang SH, Zhu HT, Yu JH, Xu GQ. Effectiveness of mesalazine to treat irritable bowel syndrome: A meta-analysis. Medicine (Baltimore) 2019;98:e16297. [PMID: 31305414 DOI: 10.1097/MD.0000000000016297] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
82 Jolley J. High-dose rifaximin treatment alleviates global symptoms of irritable bowel syndrome. Clin Exp Gastroenterol 2011;4:43-8. [PMID: 21694871 DOI: 10.2147/CEG.S18051] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
83 张鸣鸣, 姜敏. 肠易激综合征发病机制研究进展. 世界华人消化杂志 2009; 17(24): 2484-2490 [DOI: 10.11569/wcjd.v17.i24.2484] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
84 van der Veek PP, Dusseldorp E, van Rood YR, Masclee AA. Testing a biobehavioral model of irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2010;22:412-419. [PMID: 19898242 DOI: 10.1097/meg.0b013e328332f83f] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
85 Barbara G, Stanghellini V, Cremon C, De Giorgio R, Corinaldesi R. Almost all irritable bowel syndromes are post-infectious and respond to probiotics: controversial issues. Dig Dis 2007;25:245-8. [PMID: 17827949 DOI: 10.1159/000103894] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
86 Xu XJ, Zhang YL, Liu L, Pan L, Yao SK. Increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome: a preliminary explorative study. Aliment Pharmacol Ther. 2017;45:100-114. [PMID: 27862119 DOI: 10.1111/apt.13848] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
87 Schaeffer DF, Kirsch R, Riddell RH. Mast cells and intestinal motility disorders (mastocytic enteritis/colitis). Dig Dis Sci 2012;57:1118-21. [PMID: 22466075 DOI: 10.1007/s10620-012-2123-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
88 Barbara G, Cremon C, Carini G, Bellacosa L, Zecchi L, De Giorgio R, Corinaldesi R, Stanghellini V. The immune system in irritable bowel syndrome. J Neurogastroenterol Motil. 2011;17:349-359. [PMID: 22148103 DOI: 10.5056/jnm.2011.17.4.349] [Cited by in Crossref: 119] [Cited by in F6Publishing: 110] [Article Influence: 11.9] [Reference Citation Analysis]
89 Zanini B, Lanzarotto F, Villanacci V, Carabellese N, Ricci C, Lanzini A. Clinical expression of lymphocytic duodenosis in “mild enteropathy” celiac disease and in functional gastrointestinal syndromes. Scandinavian Journal of Gastroenterology 2014;49:794-800. [DOI: 10.3109/00365521.2014.919017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
90 Rahimi R, Abdollahi M. Herbal medicines for the management of irritable bowel syndrome: A comprehensive review. World J Gastroenterol 2012; 18(7): 589-600 [PMID: 22363129 DOI: 10.3748/wjg.v18.i7.589] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 56] [Article Influence: 6.2] [Reference Citation Analysis]
91 Katos AM, Conti ML, Moran TS, Gordon RK, Doctor BP, Sciuto AM, Nambiar MP. Abdominal bloating and irritable bowel syndrome like symptoms following microinstillation inhalation exposure to chemical warfare nerve agent VX in guinea pigs. Toxicol Ind Health 2007;23:231-40. [DOI: 10.1177/0748233707081720] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
92 Akiho H, Ihara E, Nakamura K. Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome. World J Gastrointest Pathophysiol. 2010;1:97-105. [PMID: 21607147 DOI: 10.4291/wjgp.v1.i3.97.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
93 Daulatzai MA. Chronic functional bowel syndrome enhances gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia. Neurochem Res 2014;39:624-44. [PMID: 24590859 DOI: 10.1007/s11064-014-1266-6] [Cited by in Crossref: 72] [Cited by in F6Publishing: 62] [Article Influence: 10.3] [Reference Citation Analysis]
94 Ihara E, Chappellaz M, Turner SR, MacDonald JA. The contribution of protein kinase C and CPI-17 signaling pathways to hypercontractility in murine experimental colitis. Neurogastroenterol Motil. 2012;24:e15-e26. [PMID: 22093175 DOI: 10.1111/j.1365-2982.2011.01821.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
95 Stanghellini V, Barbara G, Cogliandro R, Salvioli B, Cremon C, De Giorgio R, Corinaldesi R. Overlap Between GERD and IBS: Irrefutable But Subtle. Journal of Clinical Gastroenterology 2007;41:S114-7. [DOI: 10.1097/mcg.0b013e31803d0f94] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
96 Pimentel M, Chang C. Inflammation and microflora. Gastroenterol Clin North Am. 2011;40:69-85. [PMID: 21333901 DOI: 10.1016/j.gtc.2010.12.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
97 Palsson O, Whitehead WE. Comorbidity Associated With Irritable Bowel Syndrome. Psychiatric Annals 2005;35:320-8. [DOI: 10.3928/00485713-20050401-06] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
98 Rentzos G, Lundberg V, Stotzer PO, Pullerits T, Telemo E. Intestinal allergic inflammation in birch pollen allergic patients in relation to pollen season, IgE sensitization profile and gastrointestinal symptoms. Clin Transl Allergy 2014;4:19. [PMID: 24910772 DOI: 10.1186/2045-7022-4-19] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
99 Stanghellini V. Functional Dyspepsia and Irritable Bowel Syndrome: Beyond Rome IV. Dig Dis. 2017;35 Suppl 1:14-17. [PMID: 29421792 DOI: 10.1159/000485408] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
100 Dorofeyev AE, Kiriyan EA, Vasilenko IV, Rassokhina OA, Elin AF. Clinical, endoscopical and morphological efficacy of mesalazine in patients with irritable bowel syndrome. Clin Exp Gastroenterol. 2011;4:141-153. [PMID: 21753896 DOI: 10.21471/CEG.S18381] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
101 Kwon JG, Park KS, Park JH, Park JM, Park CH, Lee KJ, Park HJ, Rhee JC; Korean Society of Neurogastroenterology and Motility. [Guidelines for the treatment of irritable bowel syndrome]. Korean J Gastroenterol 2011;57:82-99. [PMID: 21350320 DOI: 10.4166/kjg.2011.57.2.82] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
102 Ravnefjord A, Pettersson M, Rehnström E, Martinez V. Acute colonic ischaemia in rats results in long-term structural changes without alterations of colonic sensitivity. Int J Exp Pathol 2008;89:476-89. [PMID: 19134057 DOI: 10.1111/j.1365-2613.2008.00623.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
103 Kilkens TO, Honig A, Fekkes D, Brummer RJ. The effects of an acute serotonergic challenge on brain-gut responses in irritable bowel syndrome patients and controls. Aliment Pharmacol Ther. 2005;22:865-874. [PMID: 16225497 DOI: 10.1111/j.1365-2036.2005.02660.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
104 Dorofeyev AE, Kiriyan EA, Vasilenko IV, Rassokhina OA, Elin AF. Clinical, endoscopical and morphological efficacy of mesalazine in patients with irritable bowel syndrome. Clin Exp Gastroenterol. 2011;4:141-153. [PMID: 21753896 DOI: 10.2147/ceg.s18381] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
105 Dupont HL. Gastrointestinal infections and the development of irritable bowel syndrome. Curr Opin Infect Dis 2011;24:503-8. [PMID: 21844806 DOI: 10.1097/QCO.0b013e32834a962d] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
106 Kirsch R, Riddell RH. Histopathological alterations in irritable bowel syndrome. Mod Pathol. 2006;19:1638-1645. [PMID: 17013373 DOI: 10.1038/modpathol.3800704] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
107 Corinaldesi R, Stanghellini V, Cremon C, Gargano L, Cogliandro RF, De Giorgio R, Bartesaghi G, Canovi B, Barbara G. Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study. Aliment Pharmacol Ther. 2009;30:245-252. [PMID: 19438846 DOI: 10.1111/j.1365-2036.2009.04041.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 88] [Article Influence: 7.4] [Reference Citation Analysis]
108 Otmishi P, Gordon J, El-Oshar S, Li H, Guardiola J, Saad M, Proctor M, Yu J. Neuroimmune interaction in inflammatory diseases. Clin Med Circ Respirat Pulm Med 2008;2:35-44. [PMID: 21157520 DOI: 10.4137/ccrpm.s547] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
109 Rijnierse A, Nijkamp FP, Kraneveld AD. Mast cells and nerves tickle in the tummy: implications for inflammatory bowel disease and irritable bowel syndrome. Pharmacol Ther. 2007;116:207-235. [PMID: 17719089 DOI: 10.1016/j.pharmthera.2007.06.008] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 5.1] [Reference Citation Analysis]
110 Smith JL, Bayles D. Postinfectious irritable bowel syndrome: a long-term consequence of bacterial gastroenteritis. J Food Prot 2007;70:1762-9. [PMID: 17685356 DOI: 10.4315/0362-028x-70.7.1762] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
111 Acosta RD, Cash BD. Existing and emerging therapies for irritable bowel syndrome. Expert Opin Emerg Drugs 2011;16:389-402. [PMID: 21438740 DOI: 10.1517/14728214.2011.566214] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
112 Giannini EG, Mansi C, Dulbecco P, Savarino V. Role of partially hydrolyzed guar gum in the treatment of irritable bowel syndrome. Nutrition. 2006;22:334-342. [PMID: 16413751 DOI: 10.1016/j.nut.2005.10.003] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 4.3] [Reference Citation Analysis]
113 Farzaei MH, Bahramsoltani R, Abdollahi M, Rahimi R. The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments. J Neurogastroenterol Motil. 2016;22:558-574. [PMID: 27431236 DOI: 10.5056/jnm16001] [Cited by in Crossref: 77] [Cited by in F6Publishing: 62] [Article Influence: 15.4] [Reference Citation Analysis]
114 Barbara G. Mucosal barrier defects in irritable bowel syndrome. Who left the door open? Am J Gastroenterol. 2006;101:1295-1298. [PMID: 16771952 DOI: 10.1111/j.1572-0241.2006.00667.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 4.3] [Reference Citation Analysis]
115 Lee KN, Lee OY, Choi MG, Sohn CI, Huh KC, Park KS, Kwon JG, Kim N, Rhee PL, Myung SJ. Efficacy and Safety of Tiropramide in the Treatment of Patients With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-blind, Non-inferiority Trial, Compared With Octylonium. J Neurogastroenterol Motil. 2014;20:113-121. [PMID: 24466452 DOI: 10.5056/jnm.2014.20.1.113] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
116 Hod K, Dickman R, Sperber A, Melamed S, Dekel R, Ron Y, Halpern Z, Berliner S, Maharshak N. Assessment of high-sensitivity CRP as a marker of micro-inflammation in irritable bowel syndrome: Hs-CRP in irritable bowel syndrome. Neurogastroenterology & Motility 2011;23:1105-10. [DOI: 10.1111/j.1365-2982.2011.01788.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
117 Jabari S, da Silveira AB, de Oliveira EC, Quint K, Wirries A, Neuhuber W, Brehmer A. Mucosal layers and related nerve fibres in non-chagasic and chagasic human colon--a quantitative immunohistochemical study. Cell Tissue Res 2014;358:75-83. [PMID: 24962547 DOI: 10.1007/s00441-014-1934-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
118 彭颖, 李晓波. 倍半萜内酯类治疗肠易激综合征的应用前景. 世界华人消化杂志 2017; 25(18): 1624-1632 [DOI: 10.11569/wcjd.v25.i18.1624] [Reference Citation Analysis]
119 Farhadi A, Fields JZ, Keshavarzian A. Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: Stress, intestinal hyperpermeability and inflammation. World J Gastroenterol 2007; 13(22): 3027-3030 [PMID: 17589915 DOI: 10.3748/wjg.v13.i22.3027] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 50] [Article Influence: 3.9] [Reference Citation Analysis]
120 Chen J, Chen Z, Ma L, Liang Q, Jia W, Pan Z, Zeng Y, Jiang B. Development of determination of four analytes of Zhi-Shao-San decoction using LC-MS/MS and its application to comparative pharmacokinetics in normal and irritable bowel syndrome rat plasma. Biomed Chromatogr 2014;28:1384-92. [PMID: 24687219 DOI: 10.1002/bmc.3180] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
121 Guarino MP, Sessa R, Altomare A, Cocca S, Di Pietro M, Carotti S, Schiavoni G, Alloni R, Emerenziani S, Morini S. Human colonic myogenic dysfunction induced by mucosal lipopolysaccharide translocation and oxidative stress. Dig Liver Dis. 2013;45:1011-1016. [PMID: 23891549 DOI: 10.1016/j.dld.2013.06.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
122 Mcconnell EL, Fadda HM, Basit AW. Gut instincts: Explorations in intestinal physiology and drug delivery. International Journal of Pharmaceutics 2008;364:213-26. [DOI: 10.1016/j.ijpharm.2008.05.012] [Cited by in Crossref: 300] [Cited by in F6Publishing: 262] [Article Influence: 23.1] [Reference Citation Analysis]
123 Bassett JT, Cash BD. A review of irritable bowel syndrome and an update on therapeutic approaches. Expert Opinion on Pharmacotherapy 2008;9:1129-43. [DOI: 10.1517/14656566.9.7.1129] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
124 Chichlowski M, Rudolph C. Visceral pain and gastrointestinal microbiome. J Neurogastroenterol Motil 2015;21:172-81. [PMID: 25829337 DOI: 10.5056/jnm15025] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
125 Rokkas T, Ekmektzoglou K, Niv Y. Comparative effectiveness of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: a network meta-analysis of randomized controlled studies. Ann Gastroenterol 2021;34:535-46. [PMID: 34276193 DOI: 10.20524/aog.2021.0619] [Reference Citation Analysis]
126 Thijssen AY, Clemens CH, Vankerckhoven V, Goossens H, Jonkers DM, Masclee AA. Efficacy of Lactobacillus casei Shirota for patients with irritable bowel syndrome: . European Journal of Gastroenterology & Hepatology 2016;28:8-14. [DOI: 10.1097/meg.0000000000000484] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 3.8] [Reference Citation Analysis]
127 Ducrotté P. [Irritable bowel syndrome: from the gut to the brain-gut]. Gastroenterol Clin Biol 2009;33:703-12. [PMID: 19682813 DOI: 10.1016/j.gcb.2009.07.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
128 De Giorgio R, Barbara G. Is irritable bowel syndrome an inflammatory disorder? Curr Gastroenterol Rep. 2008;10:385-390. [PMID: 18627650 DOI: 10.1007/s11894-008-0073-0] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 3.8] [Reference Citation Analysis]
129 Ostertag D, Annahazi A, Krueger D, Michel K, Demir IE, Ceyhan GO, Zeller F, Schemann M. Tryptase potentiates enteric nerve activation by histamine and serotonin: Relevance for the effects of mucosal biopsy supernatants from irritable bowel syndrome patients. Neurogastroenterol Motil 2017;29. [PMID: 28374503 DOI: 10.1111/nmo.13070] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
130 Scalera A, Di Minno MND, Tarantino G. What does irritable bowel syndrome share with non-alcoholic fatty liver disease? World J Gastroenterol 2013; 19(33): 5402-5420 [PMID: 24023483 DOI: 10.3748/wjg.v19.i33.5402] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]